Skip to main content
TipRanks
Go Ultimate75% OFF

Purple Biotec-L (PPBT.L) Financial Statements

1 Followers

Purple Biotec-L Financial Overview

Purple Biotec-L's market cap is currently $32.42M. The company's EPS TTM is $-0.31; its P/E ratio is -0.01; and it has a dividend yield of 0.96%. Purple Biotec-L has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.

Financial overview
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total Revenue$ 0.00$ 0.00$ 195.80K$ 0.00$ 0.00
Gross Profit$ -219.74K$ -62.00K$ -196.00$ -120.00$ -55.00
Operating Income$ -27.46M$ -11.01M$ -22.27M$ -22.60M$ -17.93M
EBITDA$ -26.25M$ -7.05M$ -19.72M$ -21.49M$ -17.52M
Net Income$ -26.39M$ -7.24M$ -19.88K$ -21.67M$ -18.38M
Balance Sheet
Cash & Short-Term Investments$ 9.58M$ 8.52M$ 15.41M$ 32.11M$ 47.20M
Total Assets$ 17.58M$ 37.04M$ 44.30M$ 54.62M$ 70.20M
Total Debt$ 244.05K$ 183.00K$ 351.00K$ 515.00K$ 749.00K
Net Debt$ -8.47M$ -7.22M$ -14.14M$ -14.52M$ -10.14M
Total Liabilities$ 7.91M$ 4.13M$ 10.01M$ 7.52M$ 5.09M
Stockholders' Equity$ 9.72M$ 32.86M$ 34.21M$ 46.91M$ 64.83M
Cash Flow
Free Cash Flow$ -5.95M$ -14.37M$ -19.93M$ -16.96M$ -15.19M
Operating Cash Flow$ -5.95M$ -14.37M$ -19.93M$ -16.73M$ -15.07M
Investing Cash Flow$ 482.78K$ 509.00K$ 13.88M$ 19.91M$ 13.41M
Financing Cash Flow$ 6.88M$ 6.77M$ 5.45M$ 1.11M$ 1.51M

Currency in USD

Purple Biotec-L Earnings and Revenue History

-30M-15M015M-15000 %-10000 %-5000 %0 %EarningsProfit Margin201720182019202020212022202320242025RevenueEarningsProfit Margin

Purple Biotec-L Liabilities to Assets

030M60M90M0 %20 %40 %60 %LiabilitiesLiabilities to Assets201720182019202020212022202320242025AssetsLiabilitiesLiabilities to Assets

Purple Biotec-L Cash Flow

-75M-50M-25M025M50M75M201720182019202020212022202320242025OperatingInvestingFinancing

Purple Biotec-L Forecast EPS vs Actual EPS